Eagle PathoClear is an all-in-one broad spectrum antimicrobial formula offering protection against digestive and mild upper respiratory tract infections. PathoClear contains ingredients with demonstrated antimicrobial activity including Garlic, Nigella and Phellodendron (in vitro). This formula also contains Thyme and Clove oils which are used in traditional Western Herbal Medicine as antimicrobial, antiparasitic, anthelmintic and anti-inflammatory agents.
Eagle Pathoclear May Assist With
- Gastrointestinal infections
- Symptoms of bloating, flatulence and mild diarrhoea.
- Parasitic infections.
- Dysbiosis.
Product Size:60 Tablets
The active ingredients inEagle Pathoclear, when professionally prescribed, may assist patients suffering from specific health conditions.
This statement does not imply or make a claim for a cure for disorders treated withEaglePathoclear and therefore its use should be based on published scientific and clinical data as well as traditional uses.
Shipping, Refunds and Returns
Please view our policies below;
Eagle Pathoclear per Tablet
| Thyme oil | 5mg |
| Clove bud oil | 5mg |
| Allium sativum (Garlic) | 684mg |
| Phellodendron amurense (Phellodendron) | 5.6g |
| Nigella sativa (Nigella | 1g |
| Cinnamomum verum (Cinnamon) | 500mg |
Eagle Pathoclear Excipents:
Calcium hydrogen phosphate dihydrate, colloidal anhydrous silica, croscarmellose sodium,dextrin, dl-alpha-tocopherol, garlic bulb powder, hydrochloric acid, hypromellose, magnesium stearate, microcrystalline cellulose and silicon dioxide.
Eagle Pathoclear Dosage:
Adults: Take 3 tablets daily for acute infection followed by 1 tablet daily or as directed by your healthcare practitioner.
Eagle Pathoclear - Contra-indications, Interactions or Cautions
- Do not use if you have allergies to any of the ingredients.
- Eagle Pathoclear is only for adults only and should not be used if pregnant or breastfeeding.
- For all Cautions, Interactions or Contra-indications associated withEagle Pathoclear please contact your health care professional.
